Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Buy
55
CKPT Quote, Financials, Valuation and Earnings
Last price:
$3.99
Seasonality move
:
1.45%
Day range:
$3.97 - $4.00
52-week range:
$1.38 - $4.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.7M
Avg. volume:
4.6M
1-year change:
118.03%
Market cap:
$334.2M
Revenue:
$41K
EPS (TTM):
-$1.84
Earnings Data
Next earnings date for CKPT
May 09
2025
Most recent earnings per share
-$0.69
Missed by $0.69
(Mar 28/2025)
Consensus Estimate
--
(Mar 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CKPT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $7.3M | -- | -- | -$0.02 | -- |
| 05/09/2025 | Q1 | -- | -- | -- | -$0.10 | -- |
| 03/28/2025 | Q4 | -- | -- | -$0.69 | -- | -- |
| 11/12/2024 | Q3 | $10.3K | -- | -$0.23 | -- | -- |
| 08/12/2024 | Q2 | $10.3K | $41K | -$0.18 | -- | -- |
| 05/10/2024 | Q1 | $10K | -- | -$0.33 | -- | -- |
| 03/22/2024 | Q4 | $22.5K | $6K | -$1.10 | -- | -- |
| 11/13/2023 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/14/2023 | Q2 | -- | -- | -$1.05 | -- | -- |
| 05/15/2023 | Q1 | -- | -- | -$0.89 | -- | -- |
| 03/30/2023 | Q4 | -- | -- | -$2.31 | -- | -- |
| 11/08/2022 | Q3 | -- | -- | -$1.20 | -- | -- |
| 08/12/2022 | Q2 | -- | -- | -$1.62 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$1.98 | -- | -- |
| 03/28/2022 | Q4 | -- | -- | -$3.85 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$1.40 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$1.20 | -- | -- |
| 05/07/2021 | Q1 | -- | -- | -$0.90 | -- | -- |
| 03/09/2021 | Q4 | -- | -- | -$1.70 | -- | -- |
| 11/04/2020 | Q3 | -- | -- | -$0.90 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.90 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | -$0.60 | -- | -- |
| 03/11/2020 | Q4 | -- | -- | -$2.20 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$1.50 | -- | -- |
| 05/10/2019 | Q1 | -- | -- | -$1.80 | -- | -- |
| 03/15/2019 | Q4 | -- | -- | -$3.80 | -- | -- |
| 11/02/2018 | Q3 | -- | -- | -$3.20 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$2.30 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$3.50 | -- | -- |
| 03/15/2018 | Q4 | -- | -- | -$2.60 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$2.60 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$2.80 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$2.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$3.41 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$2.10 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$2.21 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1.48 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$3.30 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$1.53 | -- | -- |
Checkpoint Therapeutics Earnings Questions
-
How Much did Checkpoint Therapeutics Generate in Revenue Last Quarter?
Checkpoint Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Checkpoint Therapeutics Beat Earnings Last Quarter?
Checkpoint Therapeutics announced earnings per share of -$0.69 which represents a miss of analyst forecast a -- per share.
-
Is Checkpoint Therapeutics Profitable?
Checkpoint Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Checkpoint Therapeutics EPS Next Year?
Checkpoint Therapeutics's earnings are forecast to decrease from -$1.42 per share to $0.27 per share next year representing a decrease of -72.87%.
-
When is Checkpoint Therapeutics's Earnings Date?
Checkpoint Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
